Get 20% lifetime commission for referring investors to digrin.com
here.
Palisade Bio, Inc. ( PALI) - Key Metrics
PALI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.05 | -$0.04 | -$0.04 |
| 2026Q1 | $0 | -$0.05 | -$0.02 | -$0.02 |
| 2025Q4 | $0 | -$0.16 | -$0.06 | -$0.06 |
| 2025Q3 | $0 | -$0.38 | -$0.48 | -$0.48 |
| 2025Q2 | $0 | -$0.58 | -$0.38 | -$0.38 |
PALI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.45 |
| 2026Q1 | 0% | -9.55 |
| 2025Q4 | 0% | -10.53 |
| 2025Q3 | 0% | -0.57 |
| 2025Q2 | 0% | -0.29 |
PALI
Price: $1.41
52 week price:
Earnings Per Share: 0.65 USD
P/E Ratio: 3.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 369800
Market Capitalization: 250.0 million